"Wall Street at this point just wants all the fen-phen litigation to go away. Even if American Home has to pay a little more than the cases deserve, Wall Street would say that's a good deal." American Home, which is fighting with competitor Pfizer, over American's planned merger with another drug maker, Warner-Lambert, saw its shares fall $1.121/2 Thursday to $43.371/2 on the New York Stock Exchange. The Linnens' suit was the first wrongful death case filed against American Home Products in connection with the fen-phen drugs, said their lawyer, Alex MacDonald. It was not the first death case settled. In Houston last year, relatives of 35-year-old Mary Marisa Smith, who claimed fen-phen killed her, agreed to settle for an undisclosed amount of money three weeks into trial.